49 related articles for article (PubMed ID: 8957077)
1. Positive and negative regulatory elements in the murine p53 promoter.
Roy B; Reisman D
Oncogene; 1996 Dec; 13(11):2359-66. PubMed ID: 8957077
[TBL] [Abstract][Full Text] [Related]
2. p53-dependent suppression of uridine phosphorylase gene expression through direct promoter interaction.
Zhang D; Cao D; Russell R; Pizzorno G
Cancer Res; 2001 Sep; 61(18):6899-905. PubMed ID: 11559567
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional suppression of multidrug resistance-associated protein (MRP) gene expression by wild-type p53.
Wang Q; Beck WT
Cancer Res; 1998 Dec; 58(24):5762-9. PubMed ID: 9865734
[TBL] [Abstract][Full Text] [Related]
5. Increased p53 transcription prior to DNA synthesis is regulated through a novel regulatory element within the p53 promoter.
Boggs K; Reisman D
Oncogene; 2006 Jan; 25(4):555-65. PubMed ID: 16158047
[TBL] [Abstract][Full Text] [Related]
6. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the human topoisomerase IIbeta (TOP2B) promoter activity: essential roles of the nuclear factor-Y (NF-Y)- and specificity protein-1 (Sp1)-binding sites.
Lok CN; Lang AJ; Mirski SE; Cole SP
Biochem J; 2002 Dec; 368(Pt 3):741-51. PubMed ID: 12197834
[TBL] [Abstract][Full Text] [Related]
8. The critical role of the PE21 element in oncostatin M-mediated transcriptional repression of the p53 tumor suppressor gene in breast cancer cells.
Li C; Ahlborn TE; Tokita K; Boxer LM; Noda A; Liu J
Oncogene; 2001 Dec; 20(57):8193-202. PubMed ID: 11781835
[TBL] [Abstract][Full Text] [Related]
9. The UV responsive elements in the human mimecan promoter: a functional characterization.
Tasheva ES; Conrad GW
Mol Vis; 2003 Jan; 9():1-9. PubMed ID: 12533723
[TBL] [Abstract][Full Text] [Related]
10. Protein-binding elements in the promoter region of the mouse p53 gene.
Ginsberg D; Oren M; Yaniv M; Piette J
Oncogene; 1990 Sep; 5(9):1285-90. PubMed ID: 2216454
[TBL] [Abstract][Full Text] [Related]
11. ING1 represses transcription by direct DNA binding and through effects on p53.
Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
[TBL] [Abstract][Full Text] [Related]
12. Positive and negative transcriptional regulation of aromatase expression in human breast cancer tissue.
Chen S; Ye J; Kijima I; Kinoshita Y; Zhou D
J Steroid Biochem Mol Biol; 2005 May; 95(1-5):17-23. PubMed ID: 15955695
[TBL] [Abstract][Full Text] [Related]
13. Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression.
Zhang L; Yu D; Hu M; Xiong S; Lang A; Ellis LM; Pollock RE
Cancer Res; 2000 Jul; 60(13):3655-61. PubMed ID: 10910082
[TBL] [Abstract][Full Text] [Related]
14. The repressive function of AP2 transcription factor on the hepatocyte growth factor gene promoter.
Jiang JG; DeFrances MC; Machen J; Johnson C; Zarnegar R
Biochem Biophys Res Commun; 2000 Jun; 272(3):882-6. PubMed ID: 10860846
[TBL] [Abstract][Full Text] [Related]
15. p53 upregulates death receptor 4 expression through an intronic p53 binding site.
Liu X; Yue P; Khuri FR; Sun SY
Cancer Res; 2004 Aug; 64(15):5078-83. PubMed ID: 15289308
[TBL] [Abstract][Full Text] [Related]
16. Isolation and initial characterization of the BRCA2 promoter.
Davis PL; Miron A; Andersen LM; Iglehart JD; Marks JR
Oncogene; 1999 Oct; 18(44):6000-12. PubMed ID: 10557089
[TBL] [Abstract][Full Text] [Related]
17. Two Sp sites are important cis elements regulating the upstream promoter region of the gene for rat type I hexokinase.
Liu W; Wilson JE
Arch Biochem Biophys; 1997 Oct; 346(1):142-50. PubMed ID: 9328294
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation of the hepatocyte growth factor (HGF) gene by the Sp family of transcription factors.
Jiang JG; Chen Q; Bell A; Zarnegar R
Oncogene; 1997 Jun; 14(25):3039-49. PubMed ID: 9223667
[TBL] [Abstract][Full Text] [Related]
19. Transcription factors Oct-1 and NF-YA regulate the p53-independent induction of the GADD45 following DNA damage.
Jin S; Fan F; Fan W; Zhao H; Tong T; Blanck P; Alomo I; Rajasekaran B; Zhan Q
Oncogene; 2001 May; 20(21):2683-90. PubMed ID: 11420680
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional regulation of the murine Elf3 gene in embryonal carcinoma cells and their differentiated counterparts: requirement for a novel upstream regulatory region.
Hou J; Wilder PJ; Bernadt CT; Boer B; Neve RM; Rizzino A
Gene; 2004 Sep; 340(1):123-31. PubMed ID: 15556300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
